Press Releases
Post a press release | Manage press releases
-
Archō’s ELAVAY Oncology Report Names Eli Lilly the Company Cancer Advocates Trust Most
Press release from Archō Advocacy, LLC • Sept. 30, 2026 -
Convert Pharmaceuticals' Experimental Cancer Drug Shrinks Tumours in Patients Who Had Run Out of Options
Press release from Convert Pharma • Sept. 29, 2026 -
New Science Paper Identifies a Shared Adenosine Signaling Pathway That Causes Cardiac Fibrosis
Press release from Greenstone Biosciences • Sept. 24, 2026 -
Acrosian Partners with ZenQMS to Strengthen Quality Infrastructure as Biometrics CRO Expands
Press release from Acrosian • Sept. 23, 2026 -
ISPE San Francisco Bay Area Chapter Introduces Discovery to Delivery: Digital Enablers Summit
Press release from ISPE San Francisco Bay Area • Sept. 22, 2026 -
Archō’s ELAVAY Mental Health Report Names Neurocrine Biosciences the Company Mental Health Advocates Trust Most
Press release from Archō Advocacy, LLC • Sept. 22, 2026 -
Sapient Launches GCLP-Compliant Workflows to Expand Support for Clinical Biomarker Testing
Press release from Sapient • Sept. 22, 2026 -
Siemens Healthineers and Novo Join Forces to Advance Care for People Living with MASLD and MASH
Press release from Siemens Healthineers • Sept. 21, 2026 -
VERDOT Opens its New Centre of Excellence and Manufacturing Facility in Saint-Beauzire, France
Press release from VERDOT • Sept. 15, 2026 -
10 Years of Growth and Innovation at Almac Pharma Services’ Charnwood
Press release from Almac Group • Sept. 15, 2026 -
ACTO Named Among Everest Group’s Top 50™ Pharmaceutical Technology Providers for 2026
Press release from ACTO • Sept. 14, 2026 -
Cellsonics to auction off high-end research and development instruments via Silicon Valley Disposition
Press release from Silicon Valley Disposition • Sept. 10, 2026 -
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded
Press release from Schrödinger, Inc. • Sept. 9, 2026 -
FDA Approves Tablet Form of Zanubrutinib for All Approved Indications
Press release from BeOne Medicines • Sept. 9, 2026 -
NeuroGT Announces FDA Clearance of Investigational New Drug Application for NGT-104, an AAV9 Gene Replacement Product for MPS IIIB
Press release from NeuroGT • Sept. 3, 2026 -
ACTO Achieves Veeva Gold Product Partner Status, Following a Nearly Decade-Long Collaboration Supporting Mutual Customer Success
Press release from ACTO • Sept. 2, 2026 -
Allegheny Health Network and The START Center for Cancer Research Announce Strategic Collaboration to Expand Patient Access to Early-Phase Cancer Trials
Press release from The START Center for Cancer Research • Aug. 25, 2026 -
Bioforum The Data Masters Expands Global Footprint with New Office and Global Capability Center in Bangalore, India
Press release from Bioforum The Data Masters • Aug. 25, 2026 -
Flexcon Announces Global Relaunch of PharmCal® BioMark with ISEGA Certification
Press release from Flexcon Company, Inc. • Aug. 24, 2026 -
Healthcare Delivery Enters a New Era as Prefilled Syringes Gain Industry Attention
Press release from Healthcare Datwyler • Aug. 20, 2026
